AstraZeneca's regional vice president of northern Europe, MartinWright, has been named regional VP for Japan, effective February 1; Bruno Angelici, who now holds this post, will become executive VP, international sales and marketing (succeeding Mike O'Brien who is retiring); and Ulf Sather has been appointed VP, Europe, while Luk Vranken takes on the post of VP, sales and marketing, in AstraZeneca's international sales and marketing organization.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze